Vaxcyte, Inc. PCVX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$946.53M-23.5% | -$766.63M-16.7% | -$657.2M-20.0% | -$547.5M-7.4% | -$509.63M-9.9% | ||
| $16.39M-0.1% | $16.4M+39.4% | $11.76M+12.2% | $10.49M+17.0% | $8.96M+27.9% | ||
| $146.19M+5.3% | $138.85M+9.1% | $127.22M+12.4% | $113.18M+15.7% | $97.81M+15.3% | ||
| -$769.93M-17.4% | -$655.58M-20.9% | -$542.15M-18.0% | -$459.55M0.0% | -$459.78M-1.6% | ||
| $10.4M-24.2% | $13.71M-9.1% | $15.08M-6.9% | $16.2M-26.9% | $22.17M-1.1% | ||
| $80.63M-81.6% | $437.35M+286% | -$234.94M+81.5% | -$1.27B+11.0% | -$1.43B+28.6% | ||
| $602.84M+29,832% | $2.01M-55.4% | $4.51M-99.7% | $1.52B-6.6% | $1.63B-33.4% | ||
| -$85.86M+59.8% | -$213.77M+72.2% | -$768.96M-263% | -$211.71M+19.9% | -$264.45M-2,726% | ||
| -$780.32M-16.6% | -$669.29M-20.1% | -$557.23M-17.1% | -$475.75M+1.3% | -$481.95M-1.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vaxcyte, Inc. generate?
- Vaxcyte, Inc. (PCVX) generated -$769.9M in operating cash flow over the trailing twelve months.
- What is Vaxcyte, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Vaxcyte, Inc.'s free cash flow was -$780.3M over the trailing twelve months, down 61.9% year over year.
- Where does Vaxcyte, Inc.'s cash flow data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.